Marc N. Casper - 09 Feb 2023 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Chairman & CEO, Director
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Issuer symbol
TMO
Transactions as of
09 Feb 2023
Net transactions value
-$19,738,693
Form type
4
Filing time
13 Feb 2023, 15:35:53 UTC
Previous filing
18 Nov 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Gift $0 -1,000 -0.63% $0.000000 157,005 06 Feb 2023 Direct
transaction TMO Common Stock Gift $0 -3,300 -2.1% $0.000000 153,705 06 Feb 2023 Direct
transaction TMO Common Stock Gift $0 +3,300 $0.000000 3,300 06 Feb 2023 By Spouse
transaction TMO Common Stock Gift $0 -5,000 -3.3% $0.000000 148,705 06 Feb 2023 Direct
transaction TMO Common Stock Gift $0 +5,000 $0.000000 5,000 06 Feb 2023 By MNC 2020 Irrevocable Trust F1
transaction TMO Common Stock Options Exercise $1,576,800 +10,000 +6.7% $157.68 158,705 09 Feb 2023 Direct
transaction TMO Common Stock Sale $1,170,418 -2,059 -1.3% $568.44 156,646 09 Feb 2023 Direct F2, F3
transaction TMO Common Stock Sale $455,568 -800 -0.51% $569.46 155,846 09 Feb 2023 Direct F2, F4
transaction TMO Common Stock Sale $750,765 -1,316 -0.84% $570.49 154,530 09 Feb 2023 Direct F2, F5
transaction TMO Common Stock Sale $342,960 -600 -0.39% $571.60 153,930 09 Feb 2023 Direct F2, F6
transaction TMO Common Stock Sale $744,445 -1,300 -0.84% $572.65 152,630 09 Feb 2023 Direct F2, F7
transaction TMO Common Stock Sale $860,625 -1,500 -0.98% $573.75 151,130 09 Feb 2023 Direct F2, F8
transaction TMO Common Stock Sale $574,680 -1,000 -0.66% $574.68 150,130 09 Feb 2023 Direct F2, F9
transaction TMO Common Stock Sale $1,497,002 -2,600 -1.7% $575.77 147,530 09 Feb 2023 Direct F2, F10
transaction TMO Common Stock Sale $1,499,394 -2,600 -1.8% $576.69 144,930 09 Feb 2023 Direct F2, F11
transaction TMO Common Stock Sale $1,118,875 -1,935 -1.3% $578.23 142,995 09 Feb 2023 Direct F2, F12
transaction TMO Common Stock Sale $289,385 -500 -0.35% $578.77 142,495 09 Feb 2023 Direct F2, F13
transaction TMO Common Stock Sale $929,472 -1,600 -1.1% $580.92 140,895 09 Feb 2023 Direct F2, F14
transaction TMO Common Stock Sale $808,841 -1,390 -0.99% $581.90 139,505 09 Feb 2023 Direct F2, F15
transaction TMO Common Stock Sale $466,232 -800 -0.57% $582.79 138,705 09 Feb 2023 Direct F2, F16
transaction TMO Common Stock Options Exercise $1,576,800 +10,000 +7.2% $157.68 148,705 10 Feb 2023 Direct
transaction TMO Common Stock Sale $564,120 -1,000 -0.67% $564.12 147,705 10 Feb 2023 Direct F2, F17
transaction TMO Common Stock Sale $282,395 -500 -0.34% $564.79 147,205 10 Feb 2023 Direct F2, F18
transaction TMO Common Stock Sale $339,888 -600 -0.41% $566.48 146,605 10 Feb 2023 Direct F2, F19
transaction TMO Common Stock Sale $572,527 -1,009 -0.69% $567.42 145,596 10 Feb 2023 Direct F2, F20
transaction TMO Common Stock Sale $2,544,664 -4,475 -3.1% $568.64 141,121 10 Feb 2023 Direct F2, F21
transaction TMO Common Stock Sale $3,232,993 -5,676 -4% $569.59 135,445 10 Feb 2023 Direct F2, F22
transaction TMO Common Stock Sale $2,964,371 -5,195 -3.8% $570.62 130,250 10 Feb 2023 Direct F2, F23
transaction TMO Common Stock Sale $882,674 -1,545 -1.2% $571.31 128,705 10 Feb 2023 Direct F2, F24

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10,000 -7.9% $0.000000 116,400 09 Feb 2023 Common Stock 10,000 $157.68 Direct F25
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10,000 -8.6% $0.000000 106,400 10 Feb 2023 Common Stock 10,000 $157.68 Direct F25
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2022.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.96 to $568.95, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), (23) and (24) to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.01 to $569.81, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.01 to $570.97, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.08 to $571.88, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.10 to $572.98, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.12 to $574.11, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.12 to $575.02, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.12 to $576.09, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.17 to $577.10, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.64 to $578.63, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.64 to $578.96, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $580.41 to $581.38, inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $581.48 to $582.265, inclusive.
F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $582.50 to $583.08, inclusive.
F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.495 to $564.36, inclusive.
F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.60 to $565.21, inclusive.
F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.01 to $566.94, inclusive.
F20 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.20 to $567.78, inclusive.
F21 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.06 to $569.04, inclusive.
F22 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.06 to $570.05, inclusive.
F23 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.11 to $571.07, inclusive.
F24 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.11 to $571.56, inclusive.
F25 The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021.

Remarks:

One of two Form 4's filed on February 13, 2023 for the reporting of transactions occurring on February 9, 2023 and February 10, 2023. The second Form 4 includes additional indirect holdings that could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4.